{"version":"1.0","provider_name":"Frezza Partners","provider_url":"https:\/\/frezzapartners.com\/en\/","author_name":"Frezza Partners","author_url":"https:\/\/frezzapartners.com\/en\/author\/fr3zz4partn3rs\/","title":"AIFA approva il vaccino Nuvaxovid (Novavax) - Frezza Partners","type":"rich","width":600,"height":338,"html":"<blockquote class=\"wp-embedded-content\" data-secret=\"b56Fs3xQOz\"><a href=\"https:\/\/frezzapartners.com\/en\/aifa-approva-il-vaccino-nuvaxovid-novavax\/\">AIFA approva il vaccino Nuvaxovid (Novavax)<\/a><\/blockquote><iframe sandbox=\"allow-scripts\" security=\"restricted\" src=\"https:\/\/frezzapartners.com\/en\/aifa-approva-il-vaccino-nuvaxovid-novavax\/embed\/#?secret=b56Fs3xQOz\" width=\"600\" height=\"338\" title=\"&#8220;AIFA approva il vaccino Nuvaxovid (Novavax)&#8221; &#8212; Frezza Partners\" data-secret=\"b56Fs3xQOz\" frameborder=\"0\" marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\" class=\"wp-embedded-content\"><\/iframe><script type=\"text\/javascript\">\n\/* <![CDATA[ *\/\n\/*! This file is auto-generated *\/\n!function(d,l){\"use strict\";l.querySelector&&d.addEventListener&&\"undefined\"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!\/[^a-zA-Z0-9]\/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret=\"'+t.secret+'\"]'),o=l.querySelectorAll('blockquote[data-secret=\"'+t.secret+'\"]'),c=new RegExp(\"^https?:$\",\"i\"),i=0;i<o.length;i++)o[i].style.display=\"none\";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute(\"style\"),\"height\"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):\"link\"===t.message&&(r=new URL(s.getAttribute(\"src\")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener(\"message\",d.wp.receiveEmbedMessage,!1),l.addEventListener(\"DOMContentLoaded\",function(){for(var e,t,s=l.querySelectorAll(\"iframe.wp-embedded-content\"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute(\"data-secret\"))||(t=Math.random().toString(36).substring(2,12),e.src+=\"#?secret=\"+t,e.setAttribute(\"data-secret\",t)),e.contentWindow.postMessage({message:\"ready\",secret:t},\"*\")},!1)))}(window,document);\n\/\/# sourceURL=https:\/\/frezzapartners.com\/wp-includes\/js\/wp-embed.min.js\n\/* ]]> *\/\n<\/script>\n","thumbnail_url":"https:\/\/frezzapartners.com\/wp-content\/uploads\/2021\/12\/pexels-nataliya-vaitkevich-5863316-scaled.jpg","thumbnail_width":2560,"thumbnail_height":1707,"description":"photo by Natalyia Vaitkevic &nbsp; La Commissione Tecnico Scientifica (CTS) di AIFA, nella riunione del 22 dicembre 2021, ha approvato l\u2019utilizzo del vaccino Nuvaxovid (Novavax), rendendolo disponibile nell\u2019intera indicazione autorizzata da EMA per i soggetti di et\u00e0 uguale o superiore ai 18 anni. La vaccinazione prevede un ciclo vaccinale primario di due dosi a distanza di tre settimane l\u2019una dall\u2019altra. I dati disponibili, rileva la CTS, sul vaccino Nuvaxovid hanno mostrato una efficacia di circa il 90% nel prevenire la..."}